DR. Max sp. z o.o.

Business and other management consultancy activities

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2005-06-28
Share capital
15,835,500.00 PLN
Activity description

DR. Max operates a health platform offering over-the-counter medicines, supplements, dermocosmetics and cosmetics. The company provides online shopping, product reservations for pharmacy pickup and vaccinations in pharmacies; its own products include the Skinexpert by Dr. Max ReviHair range for hair care and supplementation.

Registered address
Krzemieniecka 60A, 54-613 Wrocław, Poland
Website
Email
Electronic delivery address
AE:PL-06310-98538-SWITR-21

Financials

Revenue history (in m)

Financial insight

  • The statement flags a going concern risk. Na dzień 31 grudnia 2025 r. skumulowane straty wyniosły 127 411 236,38 zł i przewyższyły sumę kapitału zapasowego i kapitałów rezerwowych oraz połowę kapitału zakładowego o kwotę 101 964 773,43 zł. Stosownie do wymogów art. 233 ustawy z dnia 7.12.2023 r. KSH (Dz.U. z 2024 r. poz. 18) Nadzwyczajne Zgromadzenie Wspólników w dniu 06.03.2026 podjęło uchwałę o kontynuowaniu działalności firmy.

From the notes

Current income tax (CIT due)$0

Filing timeliness

3 of 6 financial statements were filed late (the longest delay 112 days for 2021). All were audited by a statutory auditor.

  • 202515/07/2026
  • 202414/07/2025
  • 202318/07/2024
  • 202219/09/2023
  • 202104/11/2022
  • 202008/10/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.

City · Wrocław176 / 13,656
Top 1.3%
Voivodeship · Dolnośląskie364 / 23,844
Top 1.5%
Country · Poland4,961 / 297,266
Top 1.7%

Results vs industry

Revenue
This companyUSD 46.32mMedianUSD 80.78kAverageUSD 1.92m
Net profit
This companyUSD -19.80mMedianUSD 3.50kAverageUSD 117.89k
Operating costs
This companyUSD 38.17mMedianUSD 58.86kAverageUSD 1.65m
Assets
This companyUSD 87.04mMedianUSD 65.78kAverageUSD 2.86m

Websites

Trademarks

The company currently holds no active trademarks with the Polish Patent Office. 1 mark has expired or was not registered. The first mark was filed in 2015.

MarkNumberClassesStatusProtected until
Dr.Max Fluxin SKUTECZNIE ŁAGODZI OBJAWY PRZEZIĘBIENIA I GRYPY. Łagodzi bóle głowy Łagodzi katar i odblokowuje zatkany nos Zmniejsza kichanie Łagodzi ból gardła Obniża gorączkę TEN PRODUKT ZAWIERA WITAMINĘ C 10 saszetek Z.4452175Proceedings discontinued –
MarkProtected until
Dr.Max Fluxin SKUTECZNIE ŁAGODZI OBJAWY PRZEZIĘBIENIA I GRYPY. Łagodzi bóle głowy Łagodzi katar i odblokowuje zatkany nos Zmniejsza kichanie Łagodzi ból gardła Obniża gorączkę TEN PRODUKT ZAWIERA WITAMINĘ C 10 saszetek –

Authorized Representatives

Branislav Chmela age 44 – President of the Management Board
Jose Villamil Lopez age 46 – Management Board Member
Marcin Łojewski age 46 – Management Board Member
Sławomir Uherek age 54 – Management Board Member

Manner of representation

In the case of a multi-member management board, declarations of will on behalf of the company require the joint action of two members of the management board or one member of the management board jointly with a commercial proxy. In the case of a one-person management board, the company is represented by the President of the Management Board independently.

Ownership

OwnerSharesShare valueStake
Pharmax Holdings Limited
782$4,277,552.67100%

Beneficial owners

Person

Capital group

The company belongs to the Penta Investments Limited (Cyprus) group. Its direct owner is Pharmax Holdings Limited (Cyprus). The group has 33 companies, 30 of them abroad.

NameCountry
Fortuna Online Zakłady BukmacherskiePoland
ČESKÁ LÉKÁRNA HOLDING, a.s.Czechia
Dr. Max Funding CR, s.r.o.Czechia
Dr. Max Funding, s.r.o.Slovakia
Dr. Max Holding SK, a.s.Slovakia

Bank accounts

Registered as a VAT taxpayer on 2005-06-06.

Debt

No entries in the National Debtors Register (KRZ).

Real estate

TypeAmount
Buildings and premises
PLN 696K

MSiG notices

Publication dateEvent
Mar 5, 2021Merger plan
Mar 8, 2019Merger plan

Public aid

PurposeGross amount
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
–

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Competitors

Name
Agip sp. z o.o.
DR Zdrowie S.A.
Farmazona sp. z o.o.
Amber Pharm sp. z o.o.
Curate sp. z o.o.
Corax sp. z o.o.
Apte. Pl A.T. Hinz sp. j.
Vital Bis sp. z o.o.
Apteka na Górnym Borze Michał Konior i Wspólnicy sp. j.
Apteka Zabobrze Aniela Makiela, Manfred Makiela, Monika Barbara Makiela sp. j.

Change history

DateEvent
2026-10-15Share capital increase
2022-04-10PKD change
2018-12-28Share capital increase
2011-06-20Name change
2011-06-20Switch to PKD 2007

FAQ

Last updated: 2026-10-15